Ropes & Gray Advises Solmetex in its Sale to Avista Healthcare Partners

Ropes & Gray advised Solmetex, a portfolio company of AVALT and Gemini Investors, in its sale to Avista Healthcare Partners. Solmetex is the industry's leading provider of amalgam separators and other waste compliance products to the U.S. and Canadian dental industries. The transaction was announced on Dec. 17. The press release is here. 

Avalt is a family office that invests only its own principals' capital in high quality companies that have significant long-term potential. Avista Healthcare Partners is a leading New York-based private equity firm with over $6 billion invested in more than 35 growth-oriented healthcare businesses globally. Gemini Investors is a Massachusetts-based investor in smaller middle market private companies which has invested in excess of $650 million in more than 150 platform companies since its founding in 1993.

The Ropes & Gray team that advised Solmetex was led by private equity partner Charles Boer, and included private equity partner Newcomb Stillwell (both of Boston), debt finance partner Alex Zeltser (New York), tax partner Pamela Glazier, benefits partner Jennifer Rikoski, labor and employment partner Jennifer Cormier, and litigation & enforcement partner Daniel McCaughey (all of Boston).